MAY 12, 2020 5:51 AM PDT

Disabling Genes in Immune Cells Prevents Obesity

WRITTEN BY: Tara Fernandez

 

Obesity is a $1.7 trillion problem in the United States, a condition that leads to several chronic illnesses including heart disease, stroke and certain types of cancer. For many, this results in preventable, premature death. Unsurprisingly, identifying clinical strategies to prevent obesity from a pharmacological, or even a genetic standpoint have been in the research spotlight for decades.

Scientists at the Washington University School of Medicine are exploring the possibility of targeting obesity on a genetic level. By switching off a specific gene in immune cells of mice, they successfully stopped mice fed a high-fat diet from becoming obese. The study was published in The Journal of Clinical Investigation.

Obesity and inflammation are intricately linked. The number of macrophages in adipose, or fat tissue, differs depending on an individual’s metabolic status. Lean humans have around 10 percent of macrophages in adipose tissues, while obese people have up to 40 percent. Experts believe that this increased number and activity of macrophages could be linked to metabolic perturbations and the onset of associated chronic diseases in obese individuals.

 

 

By disabling the ASXL2 gene in macrophages, the researchers hypothesized that this would curb chronic low-grade inflammation in fat tissues and in turn, help resist excess weight gain in spite of high-fat diets. Their experimental model involved either genetically modifying macrophages in obese mice, or injecting them with nanoparticles that specifically target and shut off ASXL2.

Interestingly, despite being fed a high calorie diet, the treated mice burnt 45 percent more calories than mice with active macrophage ASXL2.

Principal investigator of the study, Steven L. Teitelbaum, MD, said, “These mice consumed high-fat diets, but they didn’t get fatty livers. They don’t get type 2 diabetes. It seems that limiting the inflammatory effects of their macrophages allows them to burn more fat, which keeps them leaner and healthier.”


Sources: The Journal of Clinical Investigation, Washington University in St. Louis.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JUL 12, 2021
Cell & Molecular Biology
A Molecule From the Gut Microbiome May Fight Tumors
JUL 12, 2021
A Molecule From the Gut Microbiome May Fight Tumors
The more we learn abut the gut microbiome, the more it seems that the microorganisms in our gastrointestinal tracts can ...
JUL 29, 2021
Immunology
Scientists Discover Bacterial Life on Human Fetuses
JUL 29, 2021
Scientists Discover Bacterial Life on Human Fetuses
A developing fetus in its second trimester of life is changing at an extraordinarily rapid pace––bones are b ...
AUG 05, 2021
Immunology
Nosedive: Poor Nasal Antiviral Responses Linked to Severe COVID
AUG 05, 2021
Nosedive: Poor Nasal Antiviral Responses Linked to Severe COVID
Talking, singing, coughing—all of these can spread COVID-19 from an infected person via respiratory aerosols. Thes ...
AUG 10, 2021
Immunology
An Immune Molecule Helps Create 'Good' Fat
AUG 10, 2021
An Immune Molecule Helps Create 'Good' Fat
Not all fat is ‘bad’—there’s white fat that builds up when excess calories are consumed. But, th ...
AUG 19, 2021
Cancer
Age of Colorectal Cancer Diagnosis Does not Affect Tumor Growth
AUG 19, 2021
Age of Colorectal Cancer Diagnosis Does not Affect Tumor Growth
Early-onset colorectal cancer progresses in the same way as average onset colorectal cancer. The corresponding study was ...
SEP 24, 2021
Drug Discovery & Development
WHO Recommends Antibody Treatment for High Risk COVID-19 Patients
SEP 24, 2021
WHO Recommends Antibody Treatment for High Risk COVID-19 Patients
The World Health Organization (WHO) has recommended a combination of two antibody treatments for patients at risk of adv ...
Loading Comments...